One thing that concerns me as the use of GLP-1 receptor agonists continues to grow, is how rarely we discuss muscle mass preservation during treatment
Mice labeled with Alexa647 on modified nucleic acid and fasted for 18 hours were orally administered with saline and sacrificed 2, 4, 24 hours later
It is not medical advice, but it offers a valuable look into real-world experiences - the ones often left out of clinical trial summaries
Acknowledgements The authors thank Joanna Krawczyk, Alexis Corini, Rosa Leon, Elizabeth Mietlicki-Baase, Celina Nhan and David Reiner for valuable technical assistance
As an important stakeholder in healthcare, health insurers should play their part in ensuring that GLP-1s, like all other treatments, are being utilized responsibly and at prices that enable financially sustainable treatment plans for the ongoing benefit of all